Friday, July 31, 2026

AMD’s AI Chip Sales Soar, But Still Lag Behind Nvidia’s Dominance

AMD's AI data center chip sales soared 94% to $12.6 billion, but still lag behind Nvidia's dominance in the AI semiconductor market.

FIFA Controversy: Why England’s Jarell Quansah Faces 2-Match Ban While U.S. Star Folarin Balogun Gets a Pass?

Jarell Quansah faces a two-match ban for a red card, while Folarin Balogun's suspension was deferred after Trump's intervention, raising fairness concerns.

Why Your Legs Feel Like Lead at Night—And What to Do About It

Varicose veins are common due to prolonged standing or sitting. Early treatment is vital to prevent complications and manage symptoms.

Tag: agreement

AI-Powered Antibody Drug Development: Samsung Biologics and Protina’s Game-Changing License Agreement

Samsung Bioepis and Protina sign a licensing agreement to develop AI-designed antibody drugs, aiming for candidates by 2027.

Samsung Electro-Mechanics Secures 450 Million KRW MLCC Supply Deal for AI Servers: What This Means for the Tech Industry

Samsung Electro-Mechanics has signed a $290M deal for MLCCs for AI servers, aiming to expand its product portfolio and market share.

Huons Meditech Enters Japan’s Aesthetic Market With Exclusive Distribution Agreement for Dermashine Duo_RF

Huons Meditech enters Japan's aesthetic market with its Dermashine Duo_RF device, partnering with Nifuji for distribution and sales.

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Texas Dolce Project Marks New Step in Korea Southern Power’s North American Energy Storage Strategy

Korea Southern Power signed a joint development agreement for the Dolce BESS project in Texas with HD Hyundai Electric and others.

Curiosis Expands Revvity Partnership With 110 Billion KRW Supply Deal for Live-Cell Imaging Systems

Curiosis expands its partnership with Revvity, boosting a supply contract for live cell imaging systems to 110 billion KRW, enhancing market reach.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

SK Bioscience Pours 4 Billion KRW into RSM01, Accelerating RSV Antibody Trials

SK Bioscience secures funding from the Light Foundation to support clinical trials for its RSV prevention monoclonal antibody RSM01.

How SK Chemical’s Nose-R Soft Cap Stand Out in Allergy Treatment: A Deep Dive into the OTC Market

SK Chemicals partners with Kyung Nam Pharm to enhance Nose-R Soft Cap sales in pharmacies, boosting allergy treatment distribution.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Top News

- Our Sponsors Ad -

Follow us